Found: 9
Select item for more details and to access through your institution.
LINC01152 upregulates MAML2 expression to modulate the progression of glioblastoma multiforme via Notch signaling pathway.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-020-03163-9
- By:
- Publication type:
- Article
NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
- Published in:
- Cell & Tissue Research, 2021, v. 383, n. 2, p. 693, doi. 10.1007/s00441-020-03281-y
- By:
- Publication type:
- Article
B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
- Published in:
- International Journal of Oncology, 2016, v. 49, n. 6, p. 2471, doi. 10.3892/ijo.2016.3729
- By:
- Publication type:
- Article
Preliminary results of posterior contralateral cervical 7 nerve transposition in the treatment of upper limb plegia after a stroke.
- Published in:
- Brain & Behavior, 2020, v. 10, n. 11, p. 1, doi. 10.1002/brb3.1821
- By:
- Publication type:
- Article
Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair.
- Published in:
- Cell Transplantation, 2021, v. 30, p. 1, doi. 10.1177/0963689721991466
- By:
- Publication type:
- Article
MYC‐activated lncRNA HNF1A‐AS1 overexpression facilitates glioma progression via cooperating with miR‐32‐5p/SOX4 axis.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 17, p. 6387, doi. 10.1002/cam4.3186
- By:
- Publication type:
- Article
LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy.
- Published in:
- Nano Research, 2023, v. 16, n. 7, p. 9743, doi. 10.1007/s12274-023-5568-3
- By:
- Publication type:
- Article
Suppression of Angiotensin-(1-7) on the Disruption of Blood-Brain Barrier in Rat of Brain Glioma.
- Published in:
- Pathology & Oncology Research, 2019, v. 25, n. 1, p. 429, doi. 10.1007/s12253-018-0471-z
- By:
- Publication type:
- Article
ATPase inhibitory factor 1 is a potential prognostic marker for the migration and invasion of glioma.
- Published in:
- Oncology Letters, 2015, v. 10, n. 4, p. 2075, doi. 10.3892/ol.2015.3548
- By:
- Publication type:
- Article